Youngy Health Co., Ltd. (SHE:300247)
China · Delayed Price · Currency is CNY 3.230
-0.050 (-1.52%)
Oct 30, 2026, 3:04 PM CST
Youngy Health Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 301.63 | 268.02 | 180.32 | 119.15 | 68.3 | 91.33 |
Short-Term Investments | - | 191.4 | 110.46 | 123.7 | 114.15 | 48.05 |
Trading Asset Securities | 191.95 | 315.98 | 390.48 | 373.97 | 341.03 | 144.29 |
Cash & Short-Term Investments | 493.58 | 775.4 | 681.26 | 616.82 | 523.49 | 283.67 |
Cash Growth | -5.94% | 13.82% | 10.45% | 17.83% | 84.54% | 17.24% |
Accounts Receivable | 64.87 | 88.44 | 72.63 | 41.59 | 39.36 | 35.41 |
Other Receivables | 3.54 | 6.34 | 2.78 | 4.17 | 3.69 | 20.66 |
Receivables | 68.41 | 94.78 | 75.42 | 45.75 | 43.05 | 56.07 |
Inventory | 389.24 | 201.49 | 178.26 | 143.92 | 186.57 | 149.16 |
Other Current Assets | 249.63 | 15.76 | 12.42 | 11.53 | 13.63 | 12.54 |
Total Current Assets | 1,201 | 1,087 | 947.37 | 818.02 | 766.73 | 501.44 |
Property, Plant & Equipment | 257.07 | 269.76 | 205.22 | 224.92 | 246.08 | 259.44 |
Long-Term Investments | 47.19 | 48.29 | 50.92 | 61.46 | 61.12 | 187.78 |
Other Intangible Assets | 36.7 | 38.19 | 40.57 | 42.76 | 44.9 | 55.51 |
Long-Term Deferred Tax Assets | 16.35 | 17.63 | 1.31 | 7.03 | 8.57 | 1.93 |
Long-Term Deferred Charges | 1.47 | 1.49 | 0.19 | 0.38 | 0.3 | 0.24 |
Other Long-Term Assets | 50.04 | 52.26 | 57.6 | 66.99 | 64.6 | 15.83 |
Total Assets | 1,610 | 1,515 | 1,303 | 1,222 | 1,192 | 1,022 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 93.94 | 65.36 | 58.7 | 47.38 | 52.7 | 51.97 |
Accrued Expenses | 41.3 | 60.05 | 47.99 | 34.97 | 25.1 | 31.91 |
Current Portion of Long-Term Debt | 12.43 | - | - | - | - | - |
Current Portion of Leases | - | 9.45 | 5.44 | 11.97 | 10.38 | 7.03 |
Current Income Taxes Payable | 4.88 | 3.32 | 4.96 | 1.51 | 1.51 | 1.51 |
Current Unearned Revenue | 30.47 | 22.14 | 22.07 | 23.37 | 29.48 | 28.57 |
Other Current Liabilities | 38.22 | 7.1 | 5.6 | 5.19 | 5.96 | 6.84 |
Total Current Liabilities | 221.23 | 167.44 | 144.75 | 124.4 | 125.13 | 127.83 |
Long-Term Leases | 61.26 | 70.11 | - | 5.36 | 17.04 | 25.1 |
Long-Term Unearned Revenue | 0.15 | 0.93 | - | - | - | 0.13 |
Long-Term Deferred Tax Liabilities | 27.87 | 30.16 | 16.6 | 19.09 | 21.35 | 8 |
Total Liabilities | 310.5 | 268.64 | 161.36 | 148.85 | 163.52 | 161.06 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 804.04 | 804.04 | 804.04 | 804.04 | 804.04 | 804.04 |
Additional Paid-In Capital | 1,346 | 1,346 | 1,346 | 1,346 | 1,346 | 1,346 |
Retained Earnings | -994.66 | -1,056 | -1,131 | -1,178 | -1,204 | -1,331 |
Comprehensive Income & Other | 33.06 | 44.82 | 47.13 | 45.14 | 43.83 | 12.62 |
Total Common Equity | 1,188 | 1,138 | 1,066 | 1,017 | 988.96 | 831.43 |
Minority Interest | 111.19 | 108.23 | 76.13 | 55.86 | 39.82 | 29.68 |
Shareholders' Equity | 1,299 | 1,246 | 1,142 | 1,073 | 1,029 | 861.11 |
Total Liabilities & Equity | 1,610 | 1,515 | 1,303 | 1,222 | 1,192 | 1,022 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 73.69 | 79.57 | 5.44 | 17.33 | 27.42 | 32.14 |
Net Cash (Debt) | 419.88 | 695.83 | 675.82 | 599.49 | 496.06 | 251.53 |
Net Cash Growth | -3.69% | 2.96% | 12.73% | 20.85% | 97.21% | 3.96% |
Net Cash Per Share | 0.51 | 0.84 | 0.87 | 0.68 | 0.63 | 0.31 |
Filing Date Shares Outstanding | 803.39 | 804.04 | 804.04 | 804.04 | 804.04 | 804.04 |
Total Common Shares Outstanding | 803.39 | 804.04 | 804.04 | 804.04 | 804.04 | 804.04 |
Working Capital | 979.62 | 919.99 | 802.62 | 693.62 | 641.61 | 373.61 |
Book Value Per Share | 1.48 | 1.42 | 1.33 | 1.26 | 1.23 | 1.03 |
Tangible Book Value | 1,151 | 1,100 | 1,025 | 974.09 | 944.05 | 775.92 |
Tangible Book Value Per Share | 1.43 | 1.37 | 1.27 | 1.21 | 1.17 | 0.97 |
Buildings | - | - | - | 248.92 | 248.92 | 260.62 |
Machinery | - | 77.23 | 73.16 | 70.74 | 80.92 | 85.5 |
Construction In Progress | - | 0.11 | 0.54 | 36.15 | 34.3 | 22.78 |